drugset / Trial / NCT00538265

Benefit of Immunoprophylaxis on Fibrosis to Reduce Viral Load After Liver Transplantation

NCT00538265

Phase 4 Completed 100 enrolled University Hospital, Toulouse
RandomizedParallel-groupOpen-labelTreatment

Summary

An open-label randomized multicenter clinical study comparing three regimes of immunosuppression : (A) tacrolimus and steroids, (B) antithymocyte induction therapy and full dose of tacrolimus, (C) antithymocyte induction therapy with mycophenolate mofetil and a reduced dose of tacrolimus.

Timeline

Start
2005-05
Primary completion
2010-01
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Mycophenolate Mofetil Small molecule 2 g
Comparator Tacrolimus Small molecule 0.05 mg/kg Other
Comparator Tacrolimus Small molecule 0.5 mg/kg Other
Subject antithymocyte globulins Unknown 1.5 mg/kg Intravenous

Indications

No indication recorded.